Apple officially confirmed it will disable the blood oxygen tracking on its Watch Ultra 2 and Series 9 smartwatches in the United States. The change only applies to new sales – those watches will not be able to measure SpO2 until the legal battle is over between Cupertino and medical technology company Masimo.
Current units on the market, including those that are already shipped to third-party retailers, will continue functioning as before. Users outside the United States will remain unaffected as well.
Apple Watch Series 9
Disabling the SpO2 sensor is one way for Apple to continue…
